Development of a macaque model of central post–stroke pain and challenges to understand the mechanisms

Pain Research Pub Date : 2018-12-28 DOI:10.11154/PAIN.33.275
N. Higo, K. Nagasaka
{"title":"Development of a macaque model of central post–stroke pain and challenges to understand the mechanisms","authors":"N. Higo, K. Nagasaka","doi":"10.11154/PAIN.33.275","DOIUrl":null,"url":null,"abstract":"Central post–stroke pain (CPSP) is a central neuropathic pain characterized by pain and sensory abnormalities due to central nervous system lesion following a cerebro vascular accident. Developing therapeutic interventions for CPSP is difficult because its pathophysiology is unclear. In recent years, rodent models of CPSP have been developed to address this problem. In these models, a lesion of the thalamus including the ventral posterolateral nucleus (VPL) was made by inducing a focal stroke. Using these models, cellular and molecular mechanisms that underlie pathogenesis of CPSP have been discovered. Moreover, some drugs have been suggested to ameliorate the symptoms of the rodent CPSP models. In addition to the rodent models, a primate model of CPSP might also contribute to overcoming CPSP because it is more com-patible with humans in regard to the structures and functions of brain regions which is suggested to be involved in pain in humans. Aside from humans, the macaque monkeys are the most widespread primate genus, ranging from Japan to North Africa. Since the macaque monkeys are the animal species closest to humans among those which can be used for invasive experiments, they are widely used to understand the mechanisms of the human brain. Therefore, we developed a nonhuman primate model of CPSP using macaque monkeys. Because there were individual differences among macaque monkeys, the location of the VPL in each monkey was determined by magnetic resonance imaging (MRI) and extracellular recording of neuronal activity during tactile stimulation. Thereafter, a hemorrhagic lesion was induced by injecting collagenase type IV. Histological analysis using Nissl staining revealed that most of the lesion was localized within the VPL. Several weeks after the injection, the macaques displayed behavioral changes that were interpreted as reflecting the development of both mechanical allodynia and thermal hyperalgesia. functional magnetic resonance imaging is performed to detect brain activity changes underlying CPSP using the established macaque model. The combination of the homology of pain–related cortical areas between macaques and humans with relative-ly large macaque brain enables acquisition of imaging data on par with those examined in clinical research. Therefore, the brain imaging studies using the macaque monkey provide an advantage for the translation of the findings to human patients. We believe that animal models of CPSP will contribute not only to full understanding of pathophysiology but also to the development of therapeutic interventions for it.","PeriodicalId":41148,"journal":{"name":"Pain Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11154/PAIN.33.275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Central post–stroke pain (CPSP) is a central neuropathic pain characterized by pain and sensory abnormalities due to central nervous system lesion following a cerebro vascular accident. Developing therapeutic interventions for CPSP is difficult because its pathophysiology is unclear. In recent years, rodent models of CPSP have been developed to address this problem. In these models, a lesion of the thalamus including the ventral posterolateral nucleus (VPL) was made by inducing a focal stroke. Using these models, cellular and molecular mechanisms that underlie pathogenesis of CPSP have been discovered. Moreover, some drugs have been suggested to ameliorate the symptoms of the rodent CPSP models. In addition to the rodent models, a primate model of CPSP might also contribute to overcoming CPSP because it is more com-patible with humans in regard to the structures and functions of brain regions which is suggested to be involved in pain in humans. Aside from humans, the macaque monkeys are the most widespread primate genus, ranging from Japan to North Africa. Since the macaque monkeys are the animal species closest to humans among those which can be used for invasive experiments, they are widely used to understand the mechanisms of the human brain. Therefore, we developed a nonhuman primate model of CPSP using macaque monkeys. Because there were individual differences among macaque monkeys, the location of the VPL in each monkey was determined by magnetic resonance imaging (MRI) and extracellular recording of neuronal activity during tactile stimulation. Thereafter, a hemorrhagic lesion was induced by injecting collagenase type IV. Histological analysis using Nissl staining revealed that most of the lesion was localized within the VPL. Several weeks after the injection, the macaques displayed behavioral changes that were interpreted as reflecting the development of both mechanical allodynia and thermal hyperalgesia. functional magnetic resonance imaging is performed to detect brain activity changes underlying CPSP using the established macaque model. The combination of the homology of pain–related cortical areas between macaques and humans with relative-ly large macaque brain enables acquisition of imaging data on par with those examined in clinical research. Therefore, the brain imaging studies using the macaque monkey provide an advantage for the translation of the findings to human patients. We believe that animal models of CPSP will contribute not only to full understanding of pathophysiology but also to the development of therapeutic interventions for it.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
猕猴中枢性卒中后疼痛模型的建立及其机制的研究
中枢性脑卒中后疼痛(CPSP)是一种以脑血管意外后中枢神经系统损伤引起的疼痛和感觉异常为特征的中枢神经性疼痛。由于其病理生理机制尚不清楚,因此开发针对CPSP的治疗干预措施很困难。近年来,为了解决这一问题,开发了啮齿动物CPSP模型。在这些模型中,通过诱导局灶性中风造成丘脑包括腹侧后外侧核(VPL)的病变。利用这些模型,发现了CPSP发病机制的细胞和分子机制。此外,一些药物已被建议改善啮齿动物CPSP模型的症状。除了啮齿类动物模型外,灵长类动物的CPSP模型也可能有助于克服CPSP,因为它在与人类疼痛有关的大脑区域的结构和功能方面与人类更相容。除了人类,猕猴是分布最广的灵长类动物,从日本到北非都有。由于猕猴是可用于侵入性实验的动物中最接近人类的物种,因此它们被广泛用于了解人类大脑的机制。因此,我们以猕猴为研究对象,建立了非人类灵长类动物CPSP模型。由于猕猴之间存在个体差异,因此通过核磁共振成像(MRI)和触觉刺激时神经元活动的细胞外记录来确定每只猕猴VPL的位置。随后,注射IV型胶原酶诱导出血性病变。尼氏染色组织学分析显示,大部分病变位于VPL内。注射几周后,猕猴表现出行为变化,这被解释为反映了机械性异常性痛和热痛觉过敏的发展。使用已建立的猕猴模型进行功能性磁共振成像以检测CPSP导致的脑活动变化。猕猴与人类大脑相对较大的猕猴之间疼痛相关皮质区域的同源性,使得获得的成像数据与临床研究中检查的数据相当。因此,使用猕猴的脑成像研究为将研究结果转化为人类患者提供了优势。我们相信CPSP的动物模型不仅有助于对病理生理学的充分理解,而且有助于治疗干预措施的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pain Research
Pain Research CLINICAL NEUROLOGY-
自引率
0.00%
发文量
14
期刊最新文献
Interaction between dorsal horn neuron subsets operated by a neuropeptide Y and prodynorphin promoter and its contribution to Aβ fiber–induced allodynia–like behavior in rats Expression profiles of Tmem120A ⁄ TACAN in rat skeletal muscle subjected to exercise and inflammation Expression profiles of Tmem120A ⁄ TACAN in rat skeletal muscle subjected to exercise and inflammation Outcomes of 707 cervical selective nerve root blocks using a fluoroscopy–guided posterolateral oblique approach Exploratory study of factors affecting quality of life among patients with chronic musculoskeletal pain: A cross–sectional study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1